In parallel, GPR19+ CD68+, GPR19+ ARG1+, and GPR19+ PD-L1+ cells increased in late-stage CRC, whereas GPR19+ iNOS+ cells had no variation (Fig. 2H and I). Here, CD68 is linked to colorectal carcinoma.